부산대학교 도서관

Keywords: randomized trial; type 1 diabetes; insulin pump therapy; continuous glucose monitoring (CGM) EN randomized trial type 1 diabetes insulin pump therapy continuous glucose monitoring (CGM) 889 893 5 02/03/23 20230301 NES 230301 INTRODUCTION Healthy sleep supports general health and well-being.[[1]] Sleep disturbance in type 1 diabetes (T1DM) can be caused by factors including fear of hypoglycaemia and suboptimal glucose control.[3] For example, hypoglycaemia or hyperglycaemia can disturb sleep, through mechanisms including sympathetic activation and neuropathic pain, respectively.[4] Several observational studies have suggested that hybrid closed-loop (HCL) system initiation is associated with improved sleep,[[5]] but these data could be limited by confounding and other biases. Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study. The proportion of participants with self-reported poor sleep quality (PSQI score >5) was nonsignificantly higher during the SAP period compared to the HCL period (40.5 [24.8-57.9]% vs. 29.7 [15.9-47.0]%; I P i = 0.15). Effects of closed-loop insulin delivery on glycemia during sleep and sleep quality in older adults with type 1 diabetes: results from the ORACL trial. [Extracted from the article]